Health & beauty
MucoLife Therapeutics
MucoLife Therapeutics
A Gothenburg biotech developing an inhaled drug that dissolves the mucus plugs that block the airways in COPD.
Gothenburg, Sweden. Founded in 2024 by Thaher Pelaseyed and Gunnar C. Hansson as a University of Gothenburg spin-out.
Received 1 million kronor from Vinnova to scale up manufacturing of its drug candidate MLT-001, reported on 6 November 2026.
Written by our editors from public sources, linked in our story. Not a paid placement. Founders can request a correction.